G. Staurenghi ITALY

11:30 Welcome

M.S. Figueroa SPAIN

11:32 Faricimab in Neovascular Age-Related Macular Degeneration: Year 2 Patient Case Profiles From the Phase 3 TENAYA and LUCERNE Trials

D. Zur ISRAEL

11:38 Algorithm-Based Management of Age-related Macular Degeneration – A British-Israeli Collaboration. The BI-AMD Study

G. Staurenghi ITALY

11:44 Relationship Between Number of Intermediate or Large Drusen and Geographic Atrophy Lesion Growth Rate in the Sham Groups of the OAKS, DERBY, and FILLY Trials

O. Nanegrungsunk THAILAND

11:50 Association between Hypertransmission Defects and Progression in Eyes with Intermediate Age-related Macular Degeneration

M. Cozzi ITALY

11:56 Macular neovascularization area progression in eyes with neovascular age-related macular degeneration treated with vascular endothelial grow factors inhibitors using a treat-and-extend or a Pro re nata regimen.
Four-year results of the LANEX study

M. Battista ITALY

12:02 Inner and Outer Choroidal changes in the Fellow Eye of Patients with Unilateral Central Serous Chorioretinopathy

R. Liegl GERMANY

12:08 Quantitative Autofluorescence in patients with central serous chorioretinopathy

N. Sahoo INDIA

12:14 Ten-year follow-up of structural and functional changes in Central Serous Chorioretinopathy: a multimodal imaging-based studyn

U. Limon TURKEY

12:20 Elevated serum fibrinogen/albumin ratios in patients with acute central serous chorioretinopathy

All Faculty

12:26 Discussion